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Abstract 26 
Neutrophils release neutrophil extracellular traps (NETs) which ensnare pathogens and have 27 
pathogenic functions in diverse diseases. We examined the NETosis pathways induced by 28 
five stimuli; PMA, the calcium ionophore A23187, nigericin, Candida albicans and Group B 29 
Streptococcus. We studied NET production in neutrophils from healthy donors with inhibitors 30 
of molecules crucial to PMA induced NETs including protein kinase C, calcium, reactive 31 
oxygen species, the enzymes myeloperoxidase (MPO) and neutrophil elastase. Additionally, 32 
neutrophils from chronic granulomatous disease patients, carrying mutations in the NADPH 33 
oxidase complex or a MPO-deficient patient were examined. We show that PMA, C. albicans 34 
and GBS use a related pathway for NET induction whereas ionophores require an alternative 35 
pathway but that NETs produced by all stimuli are proteolytically active, kill bacteria and 36 
composed mainly of chromosomal DNA. Thus, we demonstrate that NETosis occurs through 37 
several signalling mechanisms, suggesting that extrusion of NETs is important in host 38 
defence.  39 
 40 
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Introduction 50 
Neutrophils are the most abundant white blood cell in the circulation and serve as the first line 51 
of host defence against pathogen attack. They are terminally differentiated, short lived cells 52 
that emerge from the bone marrow ready to react to the presence of pathogens (Amulic et al., 53 
2012, Kolaczkowska and Kubes, 2013). Once a foreign molecule or endogenous threat is 54 
identified the neutrophil has a battery of mechanisms it can deploy to insure optimum removal 55 
of the hazard. These include the ability to phagocytose, degranulate and produce reactive 56 
oxygen species (ROS). The neutrophil can also produce chemokines and cytokines to alert 57 
other cells in the vicinity to the danger and thus maximise the host’s immune response 58 
(Scapini and Cassatella, 2014).  59 
Another form of defence utilised by the neutrophil is the release of decondensed chromatin 60 
decorated with antimicrobial peptides that can capture the pathogen in a process termed 61 
neutrophil extracellular trap (NET) formation (Brinkmann et al., 2004). NETosis has been 62 
primarily examined in response to phorbol 12-myristate 13-acetate (PMA), a potent mitogen 63 
and a robust NET inducer. Neutrophils also initiate NETosis in response to microbial 64 
infections and, similarly to PMA, these activate protein kinase C (PKC), which in turn leads 65 
to calcium fluxes within the cell and activation of the NAPDH oxidase signalling cascade 66 
resulting in the production of reactive oxygen species (ROS) (Hakkim et al., 2011, Kaplan 67 
and Radic, 2012). The hydrogen peroxide (H2O2) produced is in turn consumed by 68 
myeloperoxidase (MPO) to produce hypochlorous acid as well as other oxidants 69 
(Papayannopoulos et al., 2010). The production of ROS is responsible for the activation of the 70 
azurosome, a protein complex composed of MPO, the serine protease neutrophil elastase (NE) 71 
and cathepsin G among other granular proteins. The generation of oxidants by MPO liberates 72 
NE from the azurosome, allowing it to translocate to the nucleus where it aids in the 73 
decondensation of the chromatin by proteolyzing histones (Metzler et al., 2014). Finally, the 74 
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cytoplasmic milieu mixes with the nuclear material as the nuclear and subsequently the 75 
plasma membrane break down, resulting in release of the NET.  76 
This study describes the different pathways leading to NETs by comparing the induction of 77 
NETosis by several stimuli. Primary neutrophils from healthy donors were treated with five 78 
stimuli: (1) PMA, (2) the calcium ionophore A23187, (3) the bacterial toxin nigericin that acts 79 
as a potassium ionophore, (4) the dimorphic fungus Candida albicans and (5) the gram 80 
positive bacteria Group B Streptococcus (GBS) and examined for the production of NETs. 81 
We tested a range of inhibitors against proteins involved in NETosis to clarify the essential 82 
elements in NET induction. 83 
To study the role of ROS in NETosis we tested neutrophils isolated from chronic 84 
granulomatous disease (CGD) patients. These patients have mutations in genes coding for 85 
subunits of the NADPH oxidase complex and as such their neutrophils cannot make ROS 86 
(Heyworth et al., 2003). Thus, these patients are highly susceptible to bacterial and fungal 87 
infections. We also tested neutrophils from a patient with a mutation in MPO. 88 
Citrullination is a post-transcriptional modification resulting in the conversion of arginine to 89 
citrulline and is catalysed by a group of calcium-dependent proteins known as 90 
peptidylarginine deiminases (PADs) (Fuhrmann et al., 2015). Recent studies have shown that 91 
citrullination occurs during NETosis (Lewis et al., 2015). We therefore also investigated if 92 
histone H3 is citrullinated during the induction of NETosis in response to the different 93 
stimuli. 94 
 Finally, we showed that the NETs generated by the five stimuli have similar properties and 95 
that NETosis is a unique form of cell death, different from classical cell death pathways 96 
involving apoptosis and necroptosis.  97 
 98 
 99 
 100 
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Results 101 
A wide range of stimuli induce Neutrophil Extracellular Traps (NETs) 102 
We selected five representative and well described NET inducers that are effective over a 2.5– 103 
4 hour time period: (1) PMA, (2) the calcium ionophore A23187 which is produced during the 104 
growth of Streptomyces chartreusensis, (3) the potassium ionophore nigericin which is 105 
derived from the bacteria Streptomyces hygroscopicus, (4) Candida albicans hyphae and (5) 106 
Streptococcus agalactiae or Group B streptococcus (GBS) and examined NETosis (Figure 107 
1A). We visualised and quantified NETs in samples that were fixed and stained with 108 
antibodies directed against a complex of histone 2A, histone 2B and chromatin (Losman et 109 
al., 1992) and against neutrophil elastase (NE). Finally, the DNA was stained with the DNA-110 
intercalating dye Hoechst 33342. We used the DNA stain to count the total number of 111 
neutrophils and NETs were quantified based on the presence of extracellular chromatin and a 112 
size exclusion protocol previously described (Brinkmann et al., 2012). Activating neutrophils 113 
with each of the stimuli resulted in a similar NET structure containing extracellular DNA co-114 
localised with NE and chromatin (Figure 1B-G).  115 
Figure 1 – figure supplement 1 shows that PMA (B), A23187 (C) and nigericin (D) produced 116 
NETs with similar kinetics over a 3-4 hour time course. C. albicans and GBS induced a 117 
slower rate of NETosis and non-stimulated cells remained NET free for the duration of the 118 
experiment. 119 
Supplemental videos 1-6 also visualise the induction of NETosis in response to the 120 
aforementioned stimuli over a 6 hour time course. All stimuli resulted in the release of 121 
extracellular DNA; however the temporal order of nucleus decondensation and plasma 122 
membrane rupture was varied. 123 
 124 
 125 
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PKC is required for PMA, C. albicans and GBS induced NETosis. Only PMA and 126 
nigericin require calcium to make NETs  127 
PMA is a direct protein kinase C (PKC) activator which, in turn, leads to calcium fluxes 128 
within the cell and both of these processes are required for PMA induced NETosis (Gupta et 129 
al., 2014, Fuchs et al., 2007). As anticipated, PMA induced NET formation was blocked by 130 
the PKC inhibitor Gö6976 (Figure 2A) (Gray et al., 2013). C. albicans and GBS NET 131 
induction was also blocked by the PKC inhibitor, albeit to a lesser degree (Figure 2C). The 132 
two ionophores, conversely, did not require PKC (Figure 2B).  133 
PMA (Figure 2D) and nigericin (Figure 2E), induced NETosis was impaired by the calcium 134 
chelator BAPTA-AM. This chelator reduced NET formation only slightly in response to 135 
A23187 (Figure 2E). Early work on neutrophil signalling revealed that ionomycin can induce 136 
a massive influx of calcium into the neutrophil, reaching a concentration greater than  1 µM 137 
(Gennaro et al., 1984). This abundance of intracellular calcium may have overwhelmed the 138 
ability of the BAPTA-AM to chelate the calcium at the concentration used. Pre-treatment of 139 
the neutrophils with higher concentrations of the calcium chelator resulted in spontaneous 140 
NET formation (data not shown) therefore making the A23187 calcium requirements difficult 141 
to assess. A previous study demonstrated a role for calcium in NETosis however, suggesting 142 
that A23187 does in fact require the calcium flux it induces to produce NETs (Gupta et al., 143 
2014). Notably, calcium chelation did not impair NETosis in response to C. albicans or GBS 144 
(Figure 2F).  145 
Finally, as previously shown for PMA and C. albicans, A23187, nigericin and GBS NET 146 
induction is independent of transcription  (Figure 2G-I) (Sollberger et al., 2016). 147 
 148 
 149 
 150 
 151 
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Differential ROS requirements of NETs 152 
Generation of reactive oxygen species (ROS) is a hallmark of PMA induced NETosis. Figure 153 
3A confirms that PMA induced a ROS burst in primary human neutrophils, peaking after 20 154 
minutes of stimulation. This ROS burst was largely abolished by pre-treating the neutrophils 155 
with the ROS scavenger pyrocatechol. A23187 (Figure 3B) also induced a ROS burst, 156 
although with slower kinetics than PMA, peaking around 80 minutes post stimulation. 157 
Pyrocatechol also prevented this ROS burst. In contrast, nigericin did not induce any ROS 158 
production (Figure 3B). Opsonized C. albicans generated ROS (Figure 3C) peaked, like PMA 159 
20 minutes after activation. GBS induced ROS production to similar levels but with slower 160 
kinetics. ROS release by both microbes was abrogated by pyrocatechol. PMA, A23187, C. 161 
albicans and GBS induced ROS returned to basal levels 2 hours post-stimulation.  162 
To test whether ROS were required for NETosis, we pre-incubated neutrophils with 163 
pyrocatechol before stimulation. As expected, ROS was absolutely required for PMA induced 164 
NETosis (Figure 3D). Conversely, pyrocatechol did not affect the level of NETosis in 165 
response to A23187 or nigericin (Figure 3E). Interestingly, C. albicans induced NETosis was 166 
impaired in the presence of the ROS scavenger, but GBS induced NETosis was not (Figure 167 
3F). 168 
To confirm the ROS requirements for NETosis we isolated neutrophils from 5 patients with 169 
chronic granulomatous disease (CGD, mutations outlined in Table 1). As expected, the 170 
neutrophils from these patients were deficient in ROS production (Figure 3 – figure 171 
supplement 1A). As previously described (Fuchs et al., 2007), CGD patient neutrophils did 172 
not undergo NETosis in response to PMA (Figure 3G) and were also significantly impaired in 173 
NET production in the presence of S. aureus (Figure 3 – figure supplement 1B).  174 
Notably, and confirming our data with the ROS scavenger, neither A23187 nor nigericin 175 
required ROS to generate NETs (Figure 3H). Intriguingly, and in contrast to data obtained 176 
with the ROS scavenger, there was no significant difference in the levels of NETosis 177 
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comparing healthy vs. CGD patient neutrophils in response to C. albicans. This discrepancy 178 
was explained by the fact that C. albicans can induce a ROS burst itself in the absence of 179 
neutrophils and this was inhibited in the presence of the ROS scavenger pyrocatechol (Figure 180 
3 – figure supplement 1C). Indeed, we confirmed that C. albicans produces sufficient ROS to 181 
allow NETosis. We pre-incubated the fungus with pyrocatechol (Figure 3 - figure supplement 182 
1D) and showed that scavenging C. albicans derived ROS also inhibited NET production. 183 
Moreover, by inhibiting ROS in both the neutrophils and the fungus NETosis was inhibited to 184 
a greater extent. Thus, the amount of ROS produced by the C. albicans was sufficient to allow 185 
NETs induction in CGD neutrophils. The amount of NETs were, however, decreased in CGD 186 
neutrophils infected with GBS (Figure 3I) when compared with cells isolated from healthy 187 
donors.  188 
Overall these data show that ROS generated by the NADPH oxidase, while absolutely 189 
essential for PMA induced NETosis, is not necessary for NET production in response to both 190 
ionophores and only partially required for C. albicans and GBS induced NETosis. 191 
 192 
Differential myeloperoxidase requirements of NETs 193 
We explored whether myeloperoxidase (MPO) is also differentially required by the different 194 
stimuli. Aminobenzoic acid hydrazide (ABAH) is a potent and irreversible small molecule 195 
inhibitor of MPO. Pre-treatment of neutrophils with ABAH did not induce spontaneous 196 
NETosis and, as anticipated, significantly decreased PMA induced NET formation (Figure 197 
4A). This was confirmed with neutrophils isolated from a MPO-deficient patient stimulated 198 
with PMA (Figure 4D). Similar to the lack of ROS requirement in NETosis in response to 199 
ionophores, the MPO inhibitor did not affect NET production by A23187 or nigericin (Figure 200 
4B) and neutrophils from a MPO-deficient individual underwent NETosis in response to both 201 
stimuli (Figure 4E). Interestingly, and contrary to the subtle role of ROS in NETosis 202 
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induction, NETs induced by C. albicans or GBS stimulation required MPO (Figure 4C and 203 
F). 204 
 205 
Downstream of ROS and MPO, neutrophil elastase is differentially required for 206 
NETosis 207 
Pre-treatment of healthy neutrophils with a highly specific small molecule NE inhibitor 208 
(Macdonald et al., 2001) did not result in spontaneous NETosis and significantly impaired 209 
PMA, C. albicans and GBS induced NETs (Figure 5A and C). NETosis in response to 210 
A23187 and nigericin did not require NE (Figure 5B). These data show that ionophores do not 211 
require the molecules relevant in other forms of NET induction such as ROS, MPO and NE.  212 
 213 
Histone citrullination occurs but is not required for NET induction 214 
Stimulation of neutrophils with A23187, nigericin, C. albicans and GBS, but not PMA, 215 
resulted in Histone 3 citrullination (cit-H3) within 90 min as shown by western blot analysis, 216 
(Figure 6A) confirming previous publications for both PMA and the calcium ionophore (Neeli 217 
and Radic, 2013). The citrullination data was confirmed by quantifying NETosis and the 218 
number of cit-H3 positive cells by immunofluorescence. Very few of the PMA induced NETs 219 
(Figure 6B) stained positively for cit-H3. Each of the other stimuli induced both NETosis and 220 
citrullination to varying levels (Figure 6C and D), confirming the data seen by western blot 221 
analysis. 222 
We next explored if citrullination was required for NET formation. Neutrophils were pre-223 
treated with three inhibitors of PAD proteins: Cl-amidine and BB-Cl-amidine, both of which 224 
inhibit PAD2 and PAD4, and Thr-Asp-F-amidine (TDFA), a potent specific PAD4 inhibitor. 225 
Treating neutrophils with Cl-amidine, BB-Cl-amidine or TDFA did not induce NETosis 226 
spontaneously (Figure 6E). PMA induced NETosis was not affected by these inhibitors, 227 
consistent with the data obtained with GSK199, another PAD4-selective inhibitor (Figure 6E) 228 
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(Lewis et al., 2015). Importantly, in response to A23187 or nigericin stimulation, NETosis 229 
remained intact after incubation with the three inhibitors (Figure 6F). Similarly, these 230 
inhibitors did not affect C. albicans or GBS induced NETosis (Figure 6G). These data are the 231 
combination of 10 independent experiments with different donors. Each individual 232 
experiment is shown in Figure 6 – figure supplement 2. The three inhibitors reduced 233 
citrullination in response to A23187, C. albicans and GBS, confirming that these inhibitors 234 
were active (Figure 6 – figure supplement 1A-C).  235 
These data show that histone H3 citrullination occurs during the course of NETosis in 236 
response to A23187, nigericin, C. albicans and GBS but not PMA induced NETs. Moreover, 237 
the inhibitor assays demonstrate that PAD2 and PAD4 are not required for NETosis. 238 
 239 
All stimuli induce NETs that are proteolytically active, kill bacteria and are composed 240 
primarily of nuclear DNA 241 
We next examined the properties of the NETs generated by the different stimuli. We began by 242 
examining the proteolytic activity of the NETs. As previously shown for PMA 243 
(Papayannopoulos et al., 2010), the induction of NETosis with all five stimuli resulted in the 244 
degradation of histone H3 at both 90 and 180 minutes (Figure 7A). Stimulation with PMA 245 
and nigericin resulted in strong degradation at the 90 minute time point and a total loss of the 246 
full length histone H3 at 180 minutes. Conversely, A23187, C. albicans and GBS stimulation 247 
led to less degradation overall. This was further confirmed by assaying the degradation of 248 
FITC-labelled casein in the presence of NETs isolated from healthy neutrophils treated with 249 
the five stimuli (Figure 7B). NETs from all five stimuli were capable of degrading FITC-250 
labelling casein to a similar level indicating they are proteolytically active. The supernatant of 251 
non-stimulated neutrophils was used to determine the background level of degradation and a 252 
known concentration of trypsin was added as a positive control. 253 
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Next we tested the ability of the NETs to kill E.coli. Healthy neutrophils were treated for 4 254 
hours with the stimuli to induce NETosis, phagocytosis was blocked with the addition of 255 
Cytochalasin D and E.coli were added for 1 hour in the presence or absence of DNase 1 (to 256 
degrade the NETs). NETs produced by all five stimuli were capable of limited killing that was 257 
blocked in the presence of DNase 1 (Figure 7C). The NETs were sonicated post E.coli 258 
incubation to release bacteria potentially trapped in clumps and skewing the killing counts. 259 
This did not affect the bacterial counts indicating that the NETs were in fact killing the 260 
bacteria. 261 
We also examined the NETs for the presence of mitochondrial DNA as this is seen in 262 
response to autoimmune stimuli such as ribonucleoprotein immune complexes (Lood et al., 263 
2016). NETs produced in response to PMA, nigericin, C. albicans and GBS contained around 264 
10% mitochondrial DNA and A23187 NETs contained around 25% (Figure 7D). This is in 265 
line with previous work demonstrating that NETs are mainly generated from chromosomal 266 
DNA (Lood et al., 2016). 267 
Taken together this data revealed that NETs produced in response to all stimuli tested can 268 
degrade proteins, kill bacteria and mostly contain nuclear DNA. 269 
 270 
NETosis is distinct from other forms of cell death 271 
To conclude, we compared NETosis, apoptosis, necrosis and necroptosis in neutrophils. We 272 
treated neutrophils with a caspase-3 inhibitor to block apoptosis or necrostatin to prevent 273 
necroptosis and measured NET formation revealing that NETosis is not affected by either of 274 
these inhibitors (Figure 8A-C).  275 
Importantly, the apoptosis inducer staurosporine did not induce NET formation even after 6 276 
hours incubation (Figure 8D). As a control, we showed that staurosporine induced apoptosis 277 
in neutrophils as demonstrated by the presence of cleaved caspase-3. This cleavage was 278 
blocked by a caspase-3 inhibitor (Figure 8 – figure supplement 1A). These data were 279 
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confirmed with the pan-caspase inhibitor Z-VAD-FMK (data not shown). As expected, 280 
staurosporine did not induce LDH release (Figure 8 – figure supplement 1B). 281 
Finally, we induced necrosis with α-hemolysin from Staphylococcus aureus or necroptosis 282 
with a cocktail of TNF-α, Z-VAD-FMK and a SMAC mimetic or cycloheximide (CHX) and 283 
measured NETosis. Neither necrosis nor necroptosis activation induced NETosis beyond the 284 
level seen in the non-stimulated cells over a 6 hour time course (Figure 8E). LDH assays 285 
confirmed that α-hemolysin and the necroptosis cocktail induced cell death (Figure 8 – figure 286 
supplement 1C and D). As a control, we verified that necrostatin blocked cell death due to 287 
necroptosis (Figure 8 – figure supplement 1D).   288 
Lastly we investigated whether LDH release occurs during NETosis. Figure 8 – figure 289 
supplement 1E showed that PMA, nigericin, C. albicans and GBS stimulation resulted in 290 
LDH release greater than non-stimulated cells at 4 hours. A23187 treatment also resulted in 291 
LDH release but to a lesser extent. 292 
In conclusion these data show that NETosis is a unique form of cell death that does not utilise 293 
components of the pathways associated with apoptosis, necrosis or necroptosis. 294 
 295 
 296 
 297 
 298 
 299 
 300 
 301 
 302 
 303 
 304 
 305 
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Discussion 306 
Recent work focusing on the various stimuli that lead to NETosis has yielded contradictory 307 
results in response to the same stimuli. These discrepancies may arise from technical issues 308 
such as differences in neutrophil isolation protocols, the culture of neutrophils in different 309 
types of cell culture media and the concentration of stimuli used. With this in mind we aimed 310 
here to confirm that our stimuli of interest generate NETs by use of the benchmark for 311 
NETosis analysis: quantifiable analysis along with fixed cell imaging and live cell videos. 312 
Using these methods, we demonstrate here that NETs can be robustly induced by a broad 313 
range of stimuli, including PMA, the ionophores A23187 and nigericin and the more 314 
physiologically relevant stimuli C. albicans and GBS. Using neutrophils isolated from healthy 315 
donors and patients as well as small molecule inhibitors, we show that NET formation occurs 316 
through different signalling pathways. The NETs generated by all five stimuli were 317 
proteolytically active, kill bacteria and are composed mainly of chromosomal DNA. We also 318 
show that NETosis is distinct from other cell death pathways such as apoptosis, necrosis and 319 
necroptosis. 320 
The data shown here demonstrates that PMA induced NETs requires PKC, calcium, ROS, 321 
MPO and NE. Conversely, Histone 3 is not citrullinated upon stimulation with PMA and 322 
transcription plays no role as has been previously shown (Sollberger et al., 2016).  323 
Clarifying the mechanisms of NET formation in response to C. albicans and GBS proved 324 
nevertheless to be challenging, perhaps due to the need to culture fresh microbes for each 325 
experiment. Similar to PMA both microbes require PKC, MPO and NE and do not require 326 
transcriptional activation for NET formation. However, both microbes induce the 327 
citrullination of histone 3. Despite this PAD4 activity is not required for NETosis in response 328 
to the microbes.  329 
The role of ROS is less conclusive as there is a discrepancy between comparing healthy 330 
neutrophils treated with ROS scavengers and cells isolated from CGD patients. Indeed, C. 331 
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albicans induces significantly less NETs when ROS were pharmacologically abrogated in 332 
neutrophils from healthy donors.  In contrast, neutrophils from CGD patients produced similar 333 
amounts of NETs as those isolated from healthy controls. This suggests that the ROS used by 334 
C. albicans do not originate from the NADPH oxidase complex. We show here that indeed C. 335 
albicans itself can produce ROS thus circumventing the ROS requirements of the neutrophil 336 
by producing sufficient levels of ROS to allow CGD neutrophils to form NETs. These results 337 
are very much in line with the clinical phenotype in which patients with CGD suffer more 338 
frequently from invasive infections with A. fumigatus than with C. albicans (Henriet et al., 339 
2012). Recently a study demonstrated that CGD patient neutrophils produce significantly less 340 
NETs in response to A. fumigatus than healthy neutrophils further adding to our evidence that 341 
neutrophils from CGD patients react diversely to fungal infections (Gazendam et al., 2016). 342 
The role of ROS in GBS induced NETosis is confounded by the ability of healthy neutrophils 343 
to produce normal levels of NETs in the presence of the ROS scavenger but a significantly 344 
reduced level of NETosis in the CGD patient neutrophils. The CGD patient data suggests a 345 
requirement for NAPDH oxidase-dependent ROS for GBS induced NETs that is perhaps not 346 
revealed by the ROS scavenger. As seen in Figure 3C, there was some residual ROS 347 
production in response to GBS in the presence of the ROS scavenger. This level of ROS may 348 
be sufficient for the GBS to induce NETosis in a manner similar to C. albicans in which the 349 
amount of ROS produced by the fungus allows NETosis to occur in the CGD patient 350 
neutrophils. It must also be noted that although the ability of GBS to induce NETosis was 351 
significantly reduced in the CGD patients, a high level of NETosis still occurred in these 352 
cells. Taken together these data suggest that while PMA absolutely relies on NADPH oxidase 353 
derived ROS for NETosis C. albicans and GBS can circumvent this need to some degree. 354 
This could be due to the ability of the microbes to generate ROS themselves that is then 355 
hijacked by the neutrophil to generate NETs in the absence of a self-source of ROS.  356 
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This is in contrast with NETosis induction by S. aureus which was dependent on the ability of 357 
the neutrophils to generate ROS as outlined in the original study on NETosis in CGD patient 358 
neutrophils (Fuchs et al., 2007). This suggests that NETosis induced by physiologically 359 
relevant stimuli is also very diverse in the signalling pathways utilised and hence challenging 360 
to clarify. Indeed, Leishmania amazonensis can induce NETosis in the absence of ROS 361 
production (Rochael et al., 2015, DeSouza-Vieira et al., 2016). 362 
Indeed the role of ROS production in the production of NETs is further confounded by recent 363 
work demonstrating that the mitochondria can also be a source of ROS in NETosis in 364 
response to calcium ionophores (Douda et al., 2015) or ribonucleoprotein-containing immune 365 
complexes (RNP ICs) (Lood et al., 2016). These data demonstrate that outside of the 366 
NADPH-oxidase complex the neutrophil has other ROS sources that are sufficient to induce 367 
NETosis.  368 
Conversely, activation with the ionophores A23187 and nigericin does not require PKC, ROS, 369 
MPO or NE or transcriptional activation and calcium only has a limited role. Histone 3 is 370 
citrullinated upon activation by these stimuli; however, pre-treatment with PAD inhibitors 371 
does not affect the ability of the neutrophils to make NETs. This suggests that citrullination 372 
(of histone 3 at least) is a consequence of NETosis, and that PAD4 is not required for NET 373 
formation. Ionophore and PMA induced NETosis appears to be distinct, at least in the few 374 
components of the signal transduction cascade already described. 375 
 A23187 is a calcium ionophore that causes a massive influx of calcium and nigericin 376 
stimulates potassium effluxes in cells which also results in the influx of calcium 377 
demonstrating the similarity between the ionophores in their mechanism of NET induction 378 
(Yaron et al., 2015). This flooding of the neutrophil with calcium ions could thus result in 379 
perturbation of the membrane potential and cell death that ultimately releases NETs. While 380 
the method to initiate NET induction by the ionophores is very different to that seen in 381 
response to PMA, the end product appears to be similar. 382 
16 
 
Auto-antibodies directed against citrullinated proteins are commonly found in the serum of 383 
rheumatoid arthritis patients (van Venrooij et al., 2004) and as such elucidating the origin of 384 
these modified proteins is of great therapeutic interest. Recent research suggests that PAD 385 
enzymes, in particular PAD4, are associated with the induction of NETosis. Consistent with 386 
this PAD4-deficient mice do not generate NETs in response to a calcium ionophore which is 387 
in direct contrast to the data presented here (Martinod et al., 2013). However, the readout for 388 
NETosis used in this study was the presence of extracellular DNA decorated with citrullinated 389 
histone 3. Since deficiency in PAD4 results in no citrullination of histones this study lacks a 390 
readout in the PAD4-deficient cells that would confirm the presence or absence of NETs such 391 
as staining with antibodies against NE or MPO on the extracellular DNA. It is also important 392 
to note that these experiments were carried out using murine neutrophils which may not 393 
behave similarly to human cells (Bardoel et al., 2014). Importantly, studies examining the 394 
requirements of the PAD enzymes in human NETosis, using the same PAD inhibitors also 395 
demonstrate a very limited inhibition of NETosis in response to a calcium ionophore and S. 396 
aureus (Hosseinzadeh et al., 2016, Lewis et al., 2015). Thus, it appears that while PAD 397 
enzymes might be important for murine neutrophils to generate NETs, this effect is not seen 398 
in human neutrophils.  399 
One additional discrepancy between our data and published reports is the observation that 400 
PAD inhibitors (both selective and pan-PAD) show efficacy in multiple mouse models of 401 
SLE and RA (Knight et al., 2015, Ghari et al., 2016, Kawalkowska et al., 2016). These studies 402 
suggest that citrullination is important in disease pathogenesis and as such could affect NET 403 
function. We do not understand how NETs function as antimicrobials, immune cell activators 404 
or in coagulation. It is possible that these NET functions are altered by the citrullination of 405 
NETs components. Indeed, the phenotype observed in the PAD4-deficient mice could 406 
potentially be attributed to the effectiveness of NETs and not necessarily NET formation. 407 
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A recent review highlights the wide range of proteins and pathways required for NETosis in 408 
response to a variety of stimuli with emphasis on the questions surrounding the role of 409 
citrullination in NETosis (Konig and Andrade, 2016). It states that ionophores and bacterial 410 
pore-forming toxins induce a pathway within neutrophils that results in the citrullination of 411 
histones but that is distinct from NETosis. They term this form of neutrophil cell death 412 
leukotoxic hypercitrullination (LTH) and suggest it is not antimicrobial but a bacterial 413 
strategy to kill neutrophils. The data shown here demonstrates that in the presence of the 414 
calcium ionophore or nigericin nuclear decondensation occurs and results in the extrusion of 415 
DNA, chromatin and antimicrobial peptides from neutrophils, albeit in a different manner to 416 
that utilised by PMA, C. albicans and GBS. Whether these extruded DNA and proteins are 417 
antimicrobial, however, requires further investigation. 418 
The different mechanisms of neutrophil cell death have been studied in detail and as such the 419 
data presented here can be included in the body of evidence that NETosis is in fact a distinct 420 
cell death mechanism utilised to aid in pathogen killing by neutrophils (Fuchs et al., 2007, 421 
Remijsen et al., 2011b, Remijsen et al., 2011a). However, two recent studies on the role of 422 
necroptosis in NETs induction present contrasting evidence for and against the requirements 423 
of necroptosis (Amini et al., 2016, Desai et al., 2016). Our data strengthens the argument that 424 
necroptosis is a separate cell death signalling cascade that is not required by neutrophils to 425 
induce NETosis. 426 
 Our observations show that there are different paths to NETosis in human cells. The 427 
elucidation of these pathways is of importance due to the ancient nature of chromatin release 428 
as a form of host defence as has been identified in both the animal and plant kingdoms. 429 
Therefore, it is unsurprising that NETosis is induced through a wide range of pathways (Tran 430 
et al., 2016).  431 
Consequently, the clarification of these different pathways to NETosis has definite therapeutic 432 
relevance. There is a genuine need to identify NET inhibitors to alleviate or prevent many 433 
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diseases including cystic fibrosis, thrombosis, malaria and sepsis (Kaplan and Radic, 2012, 434 
Brinkmann and Zychlinsky, 2012). NETs are present in the sputum of cystic fibrosis (CF) 435 
patients and contribute to the viscosity of the sputum (Manzenreiter et al., 2012). NETs are 436 
evident in the thrombus in deep vein thrombosis (DVT) and disease activity is reflective of 437 
NET markers in the plasma (Fuchs et al., 2012). Many autoimmune diseases such as Systemic 438 
lupus erythematosus (SLE) and vasculitis also show a very strong NET phenotype with 439 
regards the presence of autoantibodies against proteins readily released from neutrophils in 440 
the process of NETosis such as anti-dsDNA and anti-neutrophil cytoplasmic autoantibodies 441 
(Hakkim et al., 2010, Kessenbrock et al., 2009).  442 
This study will aid in the development of tools to help combat the detrimental effects of 443 
NETosis while balancing this with the need for the neutrophils to fulfil their purpose in the 444 
presence of a pathogen and induce their unique cell death program.  445 
 446 
 447 
 448 
 449 
 450 
 451 
 452 
 453 
 454 
 455 
 456 
 457 
 458 
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Materials and Methods 459 
Inhibitors 460 
Gö6976 (PKC, Biozol), BAPTA-AM (Thermo Fisher Scientific), Actinomycin D, 461 
GW311616A (NE) and pyrocatechol (Sigma-Aldrich), 4-Aminobenzoic acid hydrazide 462 
(ABAH, Cayman chemical), Cl-amidine (Causey and Thompson, 2008) , BB-Cl-amidine 463 
(Knight et al., 2015), TDFA (Jones et al., 2012), caspase-3 inhibitor and necrostatin (Merck-464 
Millipore). 465 
 466 
Donor consent 467 
Blood samples were collected according to the Declaration of Helsinki with study participants 468 
providing written informed consent. All samples were collected with approval from the ethics 469 
committee–Charité –Universitätsmedizin Berlin. Healthy neutrophils were isolated from 470 
blood donated anonymously at the Charité Hospital Berlin. 471 
 472 
Strains and media 473 
Candida albicans clinical isolate SC5314 was cultured overnight at 30ºC in YPD media. GBS 474 
was growth on a 6% sheep blood agar plate overnight at 37ºC, sub-cultured in Todd-Hewitt 475 
broth (Sigma-Aldrich) for 2-3 hours until the OD600nm reached 0.5. Staphylococcus aureus 476 
was prepared as previously described (Fuchs et al., 2007). E. coli XL1-Blue (Stratagene) was 477 
cultured overnight at 37ºC in LB plus tetracycline. The C. albicans, GBS and S.aureus were 478 
opsonised for 30 minutes at 37ºC with 10 % human serum before addition to the neutrophils. 479 
This ensured hyphal growth of the C. albicans. 480 
 481 
Neutrophil isolation and NET induction 482 
Human neutrophils were isolated by centrifuging heparinized venous blood over Histopaque 483 
1119 (Sigma-Aldrich) and subsequently over a discontinuous Percoll (Amersham 484 
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Biosciences) gradient as previously described (Fuchs et al., 2007). Experiments were 485 
performed in RPMI-1640 (w/o phenol red) supplemented with 10 mM HEPES and 0.05% 486 
human serum albumin. Cells were seeded at 105/well (24 well plate) for NET experiments and 487 
stimulated with PMA, staurosporine, cycloheximide (Sigma-Aldrich), A23187 (Santa Cruz 488 
Biotechnology Inc.), Nigericin (InvivoGen), Candida albicans SC5314 hyphae, GBS, α-489 
hemolysin (generated as previously described (Virreira Winter et al., 2016)), Staphylococcus 490 
aureus (prepared as previously described (Fuchs et al., 2007)), TNF-α (Thermo Fisher 491 
Scientific), z-VAD-FMK (Enzo) or SMAC mimetic (Birinapant, ChemieTek) for 2 – 6 hrs. 492 
Where applicable, cells were pre-treated inhibitors for 30 min before stimulation. 493 
 494 
NET staining and quantification 495 
Neutrophils seeded on glass coverslips were stained and quantified as previously described 496 
(Brinkmann et al., 2012). Briefly, cells were fixed in 2% paraformaldehyde (PFA) post NET 497 
induction, permeabilized on 0.5% Triton-X100, blocked for 30 min in blocking buffer. 498 
Neutrophils were then stained with the following primary antibodies: anti-neutrophil elastase 499 
(Calbiochem: 481001, RRID:AB_212213) and antibodies directed against the 500 
subnucleosomal complex of Histone 2A, Histone 2B, and chromatin ((Losman et al., 1992), 501 
generated in house). The secondary antibodies donkey anti-mouse Cy3 (Jackson 502 
ImmunoResearch Labs: 715-175-150, RRID:AB_2340819) and donkey anti- rabbit Alexa 503 
Fluor488 (Life Technologies: A11008, RRID:AB_143165) were used. Finally the samples 504 
were stained with Hoechst 33342 (Immunochemistry: 639, RRID:AB_2651135) and mounted 505 
with Mowiol. Image acquisition was done using a Leica DMR upright fluorescence 506 
microscope equipped with a Jenoptic B/W digital microscope camera and analysed using 507 
ImageJ/FIJI software. 508 
 509 
 510 
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Confocal Microscopy 511 
Primary human neutrophils (106) were washed once by centrifugation (300g, 10min, RT) in 512 
imaging medium (20mM HEPES, 2.5mM KCl, 1.8mM CaCl2, 1mM MgCl2, 0.1% Human 513 
Serum Albumin, pH 7.4) (Sigma Aldrich) and then resuspended in 4ml imaging medium 514 
containing 2µM draq5 (Biostatus) and 0.5µM Sytox Green (Thermo Fischer Scientific). Each 515 
well of an 8 well ibidi treat dish (ibidi) was filled with 200µl of that suspension and cells were 516 
allowed to settle down for 30 min at imaging temperature. NETs were induced by PMA, 517 
A23187, nigericin, C. albicans or GBS at the concentrations outlined above. Imaging was 518 
performed with a Leica SP8 AOBS confocal microscope equipped with a motorized stage and 519 
temperature-controlled chamber at 36°C. Images (2048*2048 pixels) were acquired at 0.5% 520 
maximal laser intensities every 2min for each well for a total duration of 6hrs.   521 
 522 
ROS assay  523 
Neutrophils were seeded at concentration of 1x105 cells per well in 200μl RPMI (w/o phenol 524 
red) supplemented with 10 mM HEPES, 0.05% human serum albumin, 50 μM luminol and 525 
1.2 units/ml horseradish peroxidase and pre-treated with pyrocatechol for 30min at 37°C. The 526 
cells were then stimulated for 2 hr with the indicated stimuli and luminescence was measured 527 
over time in a VICTOR Light luminescence counter from Perkin Elmer. 528 
 529 
Western blot 530 
Neutrophil lysates were generated from 5x106 cells 90, 180 minutes (cit-H3 and H3) or 3 hr 531 
(caspase-3) post stimulation by lysis in RIPA buffer (50mM Tris-HCl Ph 8.0, 150mM NaCl, 532 
1mM EDTA, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 10mM sodium fluoride, 533 
25mM sodium pyrophosphate) supplemented with protease inhibitor cocktail (Sigma-534 
Aldrich), 20 µM neutrophil elastase V inhibitor and 20 µM cathepsin G inhibitor (219372, 535 
both Calbiochem). Protein lysates were quantified by bicinchoninic acid assay (BCA assay, 536 
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Pierce) according to manufacturer’s instructions. Protein lysates were resolved by sodium 537 
dodecyl sulfate–polyacrylamide gel electrophoresis followed by analysis via Western 538 
immunoblotting using an anti-citrullinated Histone H3 primary antibody (abcam: ab5103, 539 
RRID:AB_304752), an anti-histone H3 antibody (Active Motif: 39164, discontinued) an anti-540 
cleaved Caspase-3 antibody (9661, RRID:AB_2341188), anti-β-actin (5057S, 541 
RRID:AB_10694076) or anti-GAPDH (all Cell Signaling Technology: 5014S 542 
RRID:AB_10693448) and anti-rabbit HRP (Jackson ImmunoResearch Labs: 111-035-144, 543 
RRID:AB_2307391). 544 
 545 
Protease activity assay 546 
NETs were generated as described above using 1.5x106 cells/point. The NETs were isolated 547 
as previously described (Barrientos et al., 2013). Briefly the samples were treated with 4 U/ml  548 
AluI, the NETs were collected, their DNA was quantified using the Quant-iT PicoGreen 549 
dsDNA Assay Kit (Thermo Fischer Scientific) and the protease activity of 200ng/ml of NET 550 
DNA was quantified using the Pierce Fluorescent Protease Assay kit according to the 551 
manufacturer’s instructions. 100 µl of non-stimulated neutrophil supernatant was used to 552 
calculate background protease activity and 125 ng/ml trypsin was sued as a positive control. 553 
 554 
Bacterial Killing assay 555 
NETs were generated as described above using 1x106cells/point and stimulated for 4 hrs. 556 
Bacterial killing was assayed as previously described (Ermert et al., 2009). Briefly, once 557 
NETosis was induced (visualised by light microscopy) the cells were treated with 10 µg/ml 558 
Cytochalasin D (Sigma-Aldrich) for 15 minutes to block phagocytosis. A subset of samples 559 
were treated with DNase 1 at 50 U/ml to degrade the NETs prior to killing. A tetracycline 560 
resistant E. coli strain was added to the neutrophils at an MOI of 1 and incubated at 37ºC for 1 561 
hr. The cells and E. coli were collected, a subset of samples were sonicated to release any 562 
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trapped bacteria, serially diluted, plated on tetracycline treated agar plates and incubated at 563 
37ºC for 24hr. Finally CFUs were counted. 564 
 565 
Quantitative real-time PCR of mitochondrial and nuclear content of NETs 566 
NETs were generated as described above using 1.5x106cells/point for 4 hours. NETs were 567 
released, DNA was isolated and analysed for nuclear (S18) versus mitochondrial (S16) 568 
content by Q-PCR as previously described (Lood et al., 2016). 569 
 570 
LDH assay 571 
Neutrophils were seeded at 1x105 cells/well in a 96 well plate and treated for 21hr with the 572 
indicated stimuli. LDH release was quantified from the supernatants using Cytotox 96 Non- 573 
Radioactive Cytotoxicity Assay (Promega) according to the manufacturer’s instructions. 574 
 575 
Statistics 576 
Data are presented as means ± SEM unless otherwise noted and were analysed using a two-577 
sided Student t test. All analyses were performed using GraphPad Prism software (Version 578 
6.04). Results were considered significant at P < 0.05 (*P < 0.05, **P < 0.01, ***P < 0.001). 579 
 580 
 581 
 582 
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 584 
 585 
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 789 
Donor Age Nucleotide change Mutation Amino acid change Residual activity
1 24 CYBB c.742dupA insertion p.Ile248AsnfsX36 No 
2 25 CYBB c.868C > T nonsense p.Arg290X No 
3 18 CYBB c.1421T > G missense p.Leu474Arg No 
4 26 CYBB c.868C > T nonsense p.Arg290X No 
5 29 CYBA c.371C > T missense p.Ala124Val Yes 
 790 
Table 1. CGD patient donors  791 
Nomenclature for genotypes is according to den Dunnen and Antonarakis (den Dunnen and 792 
Antonarakis, 2001). 793 
 794 
 795 
 796 
 797 
 798 
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 800 
 801 
 802 
 803 
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 805 
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 808 
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Figure Legends 809 
Figure 1. NETosis induction by a range of stimuli 810 
Primary human neutrophils were stimulated for the indicated times with 50 nM PMA, 5 µM 811 
A23187, 15 µM nigericin, MOI 5 opsonized C. albicans or MOI 10 opsonized group B 812 
streptococcus (GBS), fixed with 2% PFA and incubated with a DNA stain (Hoechst) and 813 
immunolabeled with antibodies directed against Neutrophil Elastase (NE) and chromatin (A-814 
G). (A) NETosis rate was quantified by immunofluorescence. Graph shows mean ± SEM 815 
from independent experiments with 3 different donors. (B-G) Representative confocal 816 
microscopy images of (B) non-stimulated neutrophils (-) or NETs induced by (C) PMA (D) 817 
A23187, (E) nigericin (F) C. albicans  or (G) GBS and stained with Hoechst (blue) and 818 
immunolabeled for NE (green) and chromatin (red). Scale bars, 50 μm.  819 
 820 
Figure 1 – figure supplement 1. NET induction over time with the five stimuli of interest 821 
Primary human neutrophils were stimulated for the indicated times with 50 nM PMA (B), 5 822 
µM A23187 (C), 15 µM nigericin (D), MOI 5 C. albicans (E) or MOI 10 GBS (F), fixed with 823 
2% PFA and incubated with a DNA stain (Hoechst) and immunolabeled with antibodies 824 
directed against Neutrophil Elastase (NE) and chromatin. NETosis rate was quantified by 825 
immunofluorescence. Graph shows mean ± SEM from independent experiments with 3 826 
different donors. 827 
 828 
Figure 2. Differential requirements for PKC and calcium and a lack of requirement of 829 
transcription for NET induction by the stimuli of interest 830 
(A-C) NETosis rate in PKC inhibited neutrophils. Primary neutrophils were pre-treated with 831 
the PKC inhibitor Gö6976 (1 µM) for 30 mins and stimulated with (A) PMA, (B) A23187 or 832 
nigericin, and (C) C. albicans  or GBS for 2.5 – 4 hrs and analysed for NET production by 833 
immunofluorescence. (D-F) NETosis rate in neutrophils pre-treated with the calcium chelator 834 
34 
 
BAPTA-AM (10 µM) for 30 mins and stimulated with (D) PMA, (E) A23187 or nigericin and 835 
(F) C. albicans or  GBS for 2.5 – 4 hrs and analysed for NET production by 836 
immunofluorescence. (G-I) NETosis rate in neutrophils pre-treated with actinomycin D (1 837 
µg/ml) for 30 mins and stimulated with (G) PMA, (H) A23187 or nigericin and (I) C. 838 
albicans or GBS for 2.5 – 4 hrs and then analysed for NET production by 839 
immunofluorescence. Graphs show mean ± SEM from 3 independent experiments. *P < 0.05, 840 
NS = not significant. 841 
 842 
Figure 3. Diverse stimuli have different ROS requirements for NETosis  843 
ROS production by neutrophils (A-C). ROS production was measured over a 2 hour time 844 
course in the presence or absence of the ROS scavenger pyrocatechol (pyro, 30 µM) in 845 
response to (A) PMA, (B) A23187 or nigericin and (C) C. albicans or GBS stimulation. 846 
Shown is a representative of three independent experiments. (D-F) NETosis rate of 847 
neutrophils pre-treated for 30 mins with pyrocatechol or (G-I) NETosis rate of healthy control 848 
neutrophils and CGD patients stimulated with (D & G) PMA, (E & H) A23187 or nigericin 849 
and (F & I) C. albicans or GBS. (A-C) Graphs show mean ± SD from a representative of 850 
three independent experiments. (D-F) Graphs shows mean ± SEM from 3 independent 851 
experiments. (G-I) Graphs show mean ± SEM from 5-7 independent experiments using 852 
neutrophils from 5 independent GCD patients (each represented by a red circle). *P < 0.05, ** 853 
P < 0.01, *** P < 0.001, NS = not significant.  854 
 855 
Figure 3 - figure supplement 1. No ROS production in CGD patient neutrophils, S. 856 
aureus requires ROS for NET production & C. albicans produces ROS 857 
 (A) ROS production by CGD neutrophils. Neutrophils from a healthy control donor and (B) a 858 
CGD patient were examined for the production of ROS in response to PMA stimulation over 859 
a 2 hr time course. Graph shows mean ± SD from a representative of 5 independent ROS 860 
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assays carried out with CGD patient neutrophils. (B) CGD patient neutrophils are impaired 861 
for S. aureus induced NETosis. Healthy and CGD patient neutrophils were stimulated with S. 862 
aureus at a MOI of 20 for 4hr and NETosis was examined as previously described. Graph 863 
shows mean ± SEM from 3 independent experiments. (C) C. albicans produces ROS. C. 864 
albicans induced ROS was measured over a 3 hr time course in the presence or absence of 865 
either neutrophils (PMN) or pyrocatechol (pyro). Graph shows mean ± SD from a 866 
representative of three independent experiments. (D) NETosis in response to C. albicans 867 
utilises ROS generated from C. albicans. Healthy neutrophils or C. albicans were pre-treated 868 
with pyrocatechol for 30 mins. Cells were then stimulated with C. albicans at a MOI of 5 for 869 
3hr and NETosis was examined as previously described. Graph shows mean ± SEM from 3 870 
independent experiments. 871 
 872 
Figure 4. Myeloperoxidase is essential for PMA, C. albicans and GBS induced NETosis 873 
but not for A23187 and nigericin NET formation 874 
(A-F) NETosis rate in response to (A & D) PMA, (B & E) A23187 or nigericin and (C & F) 875 
C. albicans or GBS. (A-C) Primary neutrophils were pre-treated for 30mins with 500 µM 876 
ABAH or a DMSO control, stimulated as indicated for 2.5 – 4 hrs and analysed for NET 877 
production by immunofluorescence. Graphs show mean ± SEM from 3 independent 878 
experiments. (D-F) healthy control neutrophils and neutrophils from a MPO-deficient patient 879 
were stimulated as outlined above. Graphs show mean ± SD from a representative of two 880 
independent experiments from a single MPO-deficient donor. *P < 0.05, ** P < 0.01, *** P < 881 
0.001, NS = not significant. 882 
 883 
 884 
 885 
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Figure 5. Neutrophil elastase is required for PMA, C. albicans and GBS induced 886 
NETosis but not for A23187 or nigericin NET production 887 
(A-C) NETosis rate of neutrophils during NE inhibition. Primary neutrophils were pre-treated 888 
for 30 mins with a neutrophil elastase inhibitor (GW311616A, 20 µM) or a DMSO control 889 
and stimulated for 2.5-4 hrs with (A) PMA, (B) A23187 or nigericin and (C) C. albicans or 890 
GBS and analysed for NET production by immunofluorescence. Graphs show mean ± SEM 891 
from 3 independent experiments. *P < 0.05, ** P < 0.01, *** P < 0.001, NS = not significant. 892 
 893 
Figure 6. Citrullination of histone H3 occurs during NETosis but is not required for 894 
NET induction 895 
(A-D) Histone H3 was citrullinated during NETosis in response to all stimuli bar PMA. (A) 896 
Primary neutrophils were stimulated for 90 mins with PMA, A23187, nigericin, C. albicans 897 
or GBS, lysed and assayed for the presence of citrullinated histone H3 and GAPDH by SDS-898 
PAGE electrophoresis and Western immunoblotting. (B-D) NETosis rate and percentage of 899 
citrullinated cells in response to (B) PMA, (C) A23187 or nigericin and (D) C. albicans or 900 
GBS. Graphs show mean ± SD from a representative of two independent experiments. (E-G) 901 
NETosis rate in neutrophils pre-treated with the PAD inhibitor Cl-amidine at 200 µM, BB-Cl-902 
amidine at 10 µM, TDFA at 200 µM, or DMSO as control and stimulated with (E) PMA, (F) 903 
A23187 or nigericin and (G) C. albicans or GBS and analysed for NET production by 904 
immunofluorescence. Graphs show mean ± SEM from 10 independent experiments. *P < 905 
0.05, NS = not significant. 906 
 907 
Figure 6 - figure supplement 1. PAD inhibitors reduce histone H3 citrullination 908 
Neutrophils were pre-treated with (A) 200 µM Cl-amidine, (B) 10 µM BB-Cl-amidine or (C) 909 
200 µM TDFA, stimulated with A23187, C. albicans or GBS for 3-4hrs, fixed, stained with 910 
an antibody against citrullinated histone H3 and hoechst and analysed for percentage of cells 911 
37 
 
citrullinated on histone H3 by immunofluorescence. Graphs show mean ± SEM from 3 912 
independent experiments. 913 
 914 
Figure 6 – figure supplement 2. PAD inhibitors do not prevent NETosis 915 
(A – J) Neutrophils were pre-treated with Cl-amidine at 200 µM (light grey bars), BB-Cl-916 
amidine at 10 µM (dark grey bars), TDFA (black bars) at 200 µM, or DMSO as control (white 917 
bars), stimulated with PMA, A23187, nigericin, C. albicans or GBS for 3-4hrs and analysed 918 
for NET production by immunofluorescence. Graphs show mean ± SD from 10 independent 919 
experiments.  920 
 921 
Figure 7. NETs are proteolytically active, kill bacteria and are mainly composed of 922 
chromosomal DNA 923 
(A) NETosis leads to histone H3 degradation. Primary neutrophils were stimulated for 90 and 924 
180 mins with PMA, A23187, nigericin, C. albicans or GBS, lysed and assayed for the 925 
presence of histone H3 and GAPDH by SDS-PAGE electrophoresis and Western 926 
immunoblotting. Shown is a representative of 3 independent experiments. (B) Isolated NETs 927 
are proteolytically active. NETosis was induced for 4 hr, NETs were isolated after treatment 928 
with AluI for 20min, the DNA content was determined and 200ng/ml DNA was tested for its 929 
proteolytic active using the Pierce Fluorescent Protease Assay Kit according the 930 
manufacturer’s instructions. 100 µl of non-stimulated neutrophil supernatant was used to 931 
determine the background activity and 125 ng/ml trypsin was added as a positive control. (C) 932 
NETs can kill E. coli. Neutrophils were stimulated to produce NETs for 4 hr. Phagocytosis 933 
was inhibited by the addition of Cytochalasin D and E. coli at an MOI of 1 was added in the 934 
presence or absence of 50U/ml DNase 1. After 1 hr the cells, NETs and E. coli were collected 935 
(selected samples were sonicated), serially diluted, plated on tetracycline resistant agar plates 936 
and incubated for 24hr at 37ºC followed by CFU counts to determine killing. (D) NETs are 937 
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primarily composed of chromosomal DNA. 4hr post NET induction the NETs were isolated 938 
by MNase treatment, followed by proteinase K treatment. NET DNA was isolated by phenol-939 
chloroform extraction and the ratio of S18 to S16 DNA was analysed by real-time PCR. 940 
Graphs show mean ± SEM from 3 independent experiments. 941 
 942 
Figure 8. NETosis is a unique form of cell death different from apoptosis, necrosis and 943 
necroptosis 944 
(A-C) NETosis occurs in the presence of apoptosis and necroptosis inhibitors. Primary human 945 
neutrophils were pre-treated for 30 mins with 20 µM caspase-3 inhibitor or 30 µM necrostatin 946 
or a DMSO control and stimulated with (A) PMA, (B) A23187 or nigericin and (C) C. 947 
albicans or GBS for 2.5 – 4 hrs and analysed for NET production by immunofluorescence. 948 
Graphs show mean ± SEM from 3 independent experiments. (D) NETosis rate in the presence 949 
of the apoptosis inducer staurosporine. Primary neutrophils were stimulated for 2 – 6 hrs with 950 
staurosporine (500 nM) or PMA and analysed for NET induction by immunofluorescence. 951 
Graphs show mean ± SEM from 3 independent experiments. (E) NETosis rate in response to 952 
necrosis or necroptosis inducers. Primary neutrophils were stimulated with α-hemolysin (25 953 
µg/ml) to induce necrosis or with TNF-α (50 ng/ml), Z-VAD-FMK (50 µM) and a SMAC 954 
mimetic (100 nM) or cycloheximide (25 µg/ml) to induce necroptosis for 6 hrs and analysed 955 
for NET production by immunofluorescence. Graphs show mean ± SEM from 3 independent 956 
experiments. NS = not significant.  957 
 958 
Figure 8 - figure supplement 1. Apoptosis, necrosis and necroptosis can be induced in 959 
primary neutrophils, NETosis results in LDH release 960 
(A) Staurosporine induced caspase-3 cleavage in neutrophils. Primary neutrophils were pre-961 
treated with a caspase-3 inhibitor for 30 mins, stimulated with staurosporine for 3 hrs; cell 962 
lysates were generated and assayed for the presence of cleaved caspase-3 and β-actin by SDS-963 
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PAGE electrophoresis and Western immunoblotting. Data shown is a representative of 3 964 
independent experiments. (B) Staurosporine does not induce LDH release. Neutrophils were 965 
stimulated with staurosporine for 21 hrs and LDH release was measured as per the 966 
manufacturer’s instructions. (C) Neutrophils were stimulated for 21 hrs with α-hemolysin and 967 
LDH release was measured. (D) Neutrophils were pre-treated with a necrostatin inhibitor for 968 
30 mins and stimulated with TNF-α, Z-VAD-FMK and a SMAC mimetic or cycloheximide 969 
(CHX) for 21 hrs and LDH release was measured. (C-D) Graphs show mean ± SD from a 970 
representative of two independent experiments. (E) LDH is released in NETosis. Neutrophils 971 
were treated with the indicated stimuli for 4 hrs and LDH release was measured. Graph shows 972 
mean ± SEM from 3 independent experiments. Treatment of neutrophils with triton-X100 was 973 
used to normalise the data with triton treatment set to 100% LDH release. 974 
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Supplementary figure legends 990 
Video 1. No NETosis in non-stimulated primary neutrophils  991 
Primary neutrophils were stained with Draq5 (blue) and cell impermeable Sytox Green 992 
(green) and imaged for 6 hours using a Leica SP8 AOBS confocal microscope. Video is 993 
representative of three independent experiments. 994 
 995 
Video 2. PMA induced NETosis in primary neutrophils  996 
Primary neutrophils were stained with Draq5 (blue) and cell impermeable Sytox Green 997 
(green), stimulated with 50nM PMA and imaged for 6 hours using a Leica SP8 AOBS 998 
confocal microscope. The appearance of the green colour indicated NETosis. Video is 999 
representative of three independent experiments. 1000 
 1001 
Video 3. A23187 induced NETosis in primary neutrophils  1002 
Primary neutrophils were stained with Draq5 (blue) and cell impermeable Sytox Green 1003 
(green), stimulated with 5 µM A23187 and imaged for 6 hours using a Leica SP8 AOBS 1004 
confocal microscope. The appearance of the green colour indicated NETosis. Video is 1005 
representative of three independent experiments. 1006 
 1007 
Video 4. Nigericin induced NETosis in primary neutrophils  1008 
Primary neutrophils were stained with Draq5 (blue) and cell impermeable Sytox Green 1009 
(green), stimulated with 15 µM nigericin and imaged for 6 hours using a Leica SP8 AOBS 1010 
confocal microscope. The appearance of the green colour indicated NETosis. Video is 1011 
representative of three independent experiments. 1012 
 1013 
 1014 
 1015 
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Video 5. C. albicans induced NETosis in primary neutrophils  1016 
Primary neutrophils were stained with Draq5 (blue) and cell impermeable Sytox Green 1017 
(green), stimulated with MOI 5 C. albicans and imaged for 6 hours using a Leica SP8 AOBS 1018 
confocal microscope. The appearance of the green colour indicated NETosis. Video is 1019 
representative of three independent experiments. 1020 
 1021 
Video 6. GBS induced NETosis in primary neutrophils  1022 
Primary neutrophils were stained with Draq5 (blue) and cell impermeable Sytox Green 1023 
(green), stimulated with MOI 10 GBS and imaged for 6 hours using a Leica SP8 AOBS 1024 
confocal microscope. The appearance of the green colour indicated NETosis. Video is 1025 
representative of three independent experiments. 1026 
 1027 
Supplementary File 1. Graphical abstract: The diverse mechanisms of NETosis 1028 
In this study we investigated whether NETosis occurs through a single signalling pathway or 1029 
is induced by the five stimuli of interest in a diverse mechanism. As demonstrated, NETosis 1030 
in response to C. albicans and GBS requires ROS, MPO and NE and induces histone H3 1031 
citrullination. This is in comparison to the NETosis seen in response to A23187 and nigericin 1032 
during which none of the molecules highlighted above are required but citrullination of 1033 
histone H3 does occur. Finally we re-confirm that PMA induced NETosis requires ROS, 1034 
MPO and NE but does not result in the citrullination of histone H3. 1035 
  1036 
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Titles and figure legends for source data. 1037 
Figure 1 - source data 1 1038 
This data is the mean values of three independent NETosis assays in response to the five 1039 
stimuli of interest and was used to generate the histogram in figure 1A. 1040 
 1041 
Figure 2 - source data 1 1042 
This data is the mean values of three independent NETosis assays in response to the five 1043 
stimuli of interest in the presence of the PKC inhibitor Gö6976 (figure 2A-C), the calcium 1044 
chelator BAPTA-AM (figure 2 D-F) and actinomycin D (figure 2 G-I) and was used to 1045 
generate the histograms in figure 2. 1046 
 1047 
Figure 3 - source data 1 1048 
This data is the mean values of three independent NETosis assays in response to the five 1049 
stimuli of interest in the presence of the ROS scavenger pyrocatechol and was used to 1050 
calculate the histograms in figure 3 D-F. This data also shows the means from 7 independent 1051 
experiments with CGD patient neutrophils and was used to generate the histograms in figure 3 1052 
G-I. 1053 
 1054 
Figure 4 - source data 1 1055 
This data is the mean of three independent NETosis assays in response to the five stimuli of 1056 
interest in the presence of the MPO inhibitor ABAH and was used to generate the histograms 1057 
in figure 4 A-C. This data also shows the raw data used to calculate the mean of a 1058 
representative experiment using MPO-deficient neutrophils used to generate the histograms in 1059 
figure 4 D-F. 1060 
 1061 
 1062 
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Figure 5 - source data 1 1063 
This data is the mean of three independent NETosis assays in response to the five stimuli of 1064 
interest in the presence of a NE inhibitor and was used to generate the histograms in figure 5 1065 
A-C. 1066 
 1067 
Figure 6 - source data 1 1068 
This data is the mean of ten independent NETosis assays in response to the five stimuli of 1069 
interest in the presence of the PAD inhibitors and was used to generate the histograms in 1070 
figure 6. 1071 
 1072 
Figure 8 - source data 1 1073 
This data is the mean of three independent NETosis assays in response to the five stimuli of 1074 
interest in the presence of necrostatin or caspase 3 inhibitor and was used to generate the 1075 
histograms in figure 8 A-C. This data also shows the mean of three independent NETosis 1076 
experiments in response to staurosporine (figure 8 D), hemolysin (to induce necrosis), TNF-α, 1077 
Z-VAD-FMK and a SMAC mimetic or cycloheximide (to induce necroptosis) and was used 1078 
to generate figure 8E. 1079 
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